IL-6-mediated JAK/STAT3 signaling plays a vital role in the airway remodeling of asthma, and its inhibition prevents airway inflammation and remodeling, and blocks Th2 and Th17 cell expansion in a murine asthma model (Gavino et al., 2016). Here, IL6 is linked to asthma.